Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Expert Opinion on Investigational Drugs|April 3, 2001
LHRH analogues as anticancer agents: pituitary and extrapituitary sites of actionP Limonta, M Montagnani Marelli, R M Moretti
International Journal of Cancer|May 8, 2001
Oncostatic activity of a thiazolidinedione derivative on human androgen-dependent prostate cancer cellsR M Moretti, M Montagnani Marelli, M Motta, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1992
Antiproliferative effects of luteinizing hormone-releasing hormone agonists on the human prostatic cancer cell line LNCaPP Limonta, D Dondi, R M Moretti, et al.
The Journal of Steroid Biochemistry and Molecular Biology|June 1, 1994
Androgen-dependent prostatic tumors: biosynthesis and possible actions of LHRHP Limonta, R M Moretti, D Dondi, et al.
Steroids|April 1, 1996
Growth factors in steroid-responsive prostatic tumor cellsD Dondi, R M Moretti, M M Marelli, et al.
The Prostate|November 14, 2000
Growth-inhibitory activity of melatonin on human androgen-independent DU 145 prostate cancer cellsM M Marelli, P Limonta, R Maggi, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|December 13, 1997
Effects of LHRH agonists on the growth of human prostatic tumor cells: "in vitro" and "in vivo" studiesM Montagnani Marelli, R M Moretti, D Dondi, et al.
Current Cancer Drug Targets|May 23, 2006
Gonadotropin-releasing hormone (GnRH) receptors in tumors: a new rationale for the therapeutical application of GnRH analogs in cancer patients?M Montagnani Marelli, R M Moretti, J Januszkiewicz-Caulier, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1993
Expression of luteinizing hormone-releasing hormone mRNA in the human prostatic cancer cell line LNCaPP Limonta, D Dondi, R M Moretti, et al.
Pageof 2